J. Wee

发表

Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.

K. Sommat, A. Hussain, W. Ong, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival.

H. Adami, Zhi-Hua Zhu, I. Ernberg, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma.

V. Grégoire, K. Harrington, G. Sanguineti, 2019, International journal of radiation oncology, biology, physics.

Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study.

M. Chua, J. Wee, S. Tan, 2021, Oral oncology.

Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma

J. Connolly, Bernett Lee, A. Lezhava, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Nasopharyngeal Carcinoma: Management Strategies

S. Yom, J. Wee, 2014 .

Maximizing the therapeutic ratio in the treatment of nasopharyngeal carcinoma

S. Yom, J. Wee, 2014 .

Characteristics of Radiotherapy Trials Compared With Other Oncological Clinical Trials in the Past 10 Years

Ying Sun, Ling-Long Tang, Y. Zhang, 2018, JAMA oncology.

Concurrent Chemotherapy-Enhanced Radiation: Trials and Conclusions

J. Wee, 2010 .

International Recommendations on Re-irradiation by Intensity-modulated Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma.

V. Grégoire, K. Harrington, G. Sanguineti, 2021, International journal of radiation oncology, biology, physics.

Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009.

K. Soo, B. Anderson, R. Hicks, 2009, The Lancet. Oncology.

Why we should give spatially fractionated radiation therapy (GRID) a second look—especially in nasopharyngeal carcinoma

M. Chua, J. Wee, S. Poh, 2018 .

Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials.

M. Chua, M. Shwe, G. Kusumawidjaja, 2016, European journal of cancer.

Retropharyngeal nodal metastasis related to higher rate of distant metastasis in patients with N0 and N1 nasopharyngeal cancer

S. Hee, I. Tham, J. Tuan, 2009, Head & neck.

Is nasopharyngeal cancer really a "Cantonese cancer"?

C. Qian, J. Wee, T. Ha, 2010, Chinese journal of cancer.

Carcinogenesis of nasopharyngeal carcinoma: an alternate hypothetical mechanism

M. Chua, J. Wee, S. Poh, 2016, Chinese journal of cancer.

Comparison of Four Modalities for Distant Metastases Staging in Endemic Nasopharyngeal Carcinoma

F. Gao, J. Khoo, M. Chua, 2007 .

Can external and subjective information ever be used to reduce the size of randomised controlled trials?

D. Machin, J. Wee, S. Tan, 2008, Contemporary clinical trials.

The question of T2a and N3a in the UICC/AJCC (1997) staging system for nasopharyngeal carcinoma.

J. Wee, J. Low, D. Heng, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.

J. Wee, S. Toh, S. Fook-Chong, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High incidence of nasopharyngeal cancer: similarity for 60% of mitochondrial DNA signatures between the Bidayuhs of Borneo and the Bai-yue of Southern China

C. Qian, J. Wee, S. Loong, 2012, Chinese journal of cancer.

Phenotypic and functional alterations of Vγ2Vδ2 T cell subsets in patients with active nasopharyngeal carcinoma

E. Tan, K. Puan, K. Hui, 2009, Cancer Immunology, Immunotherapy.

The most important questions in cancer research and clinical oncology

J. Wee, S. Poh, 2017, Chinese journal of cancer.

Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma

F. Gao, J. Wee, E. Chua, 2006, Head & neck.

Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients

Y. Cheung, C. Sim, D. Manton, 2014, Clinical Oral Investigations.

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison

K. Soo, D. Machin, E. Tan, 2005, British Journal of Cancer.

A Prospective 10-year Observational Study of Reduction of Radiotherapy Clinical Target Volume and Dose in Early-stage Nasopharyngeal Carcinoma.

M. Chua, J. Wee, W. Xia, 2020, International journal of radiation oncology, biology, physics.

Design of a prognostic index score for metastatic nasopharyngeal carcinoma.

E. Tan, J. Wee, K. Fong, 2003, European journal of cancer.

PD-0295 LATE TOXICITIES IN 796 PATIENTS AFTER CONVENTIONAL RADIATION THERAPY ALONE FOR NASOPHARYNGEAL CARCINOMA

I. Tham, J. Tuan, W. Ong, 2012 .

Coming of age of bevacizumab in the management of radiation-induced cerebral necrosis.

M. Chua, J. Wee, K. Chua, 2019, Annals of translational medicine.

Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.

K. Sommat, A. Hussain, W. Ong, 2017, International journal of radiation oncology, biology, physics.

Meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 4,798 patients.

Jun Ma, J. Pignon, J. Bourhis, 2014 .

Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma.

E. Tan, J. Wee, K. Fong, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results.

E. Tan, J. Wee, K. Fong, 1999, International journal of radiation oncology, biology, physics.

Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.

Jun Ma, J. Shah, Nofisat Ismaila, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic

Hung-Ming Wang, V. Grégoire, J. Machiels, 2022, The Lancet Oncology.

Phase III randomized trial of radiotherapy versus concurrent chemo-radiotherapy followed by adjuvant chemotherapy in patients with AJCC/UICC (1997) stage 3 and 4 nasopharyngeal cancer of the endemic variety.

D. Machin, E. Tan, B. Tai, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiotherapy.

M. Chua, G. Kusumawidjaja, K. Sommat, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients

Y. Cheung, C. Sim, D. Manton, 2015, Clinical Oral Investigations.

Nasopharyngeal carcinoma

Edwin P Hui, M. Chua, E. Hui, 2016, The Lancet.

Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma

M. Chua, Xiao-dong Zhu, J. Wee, 2020, Therapeutic advances in medical oncology.

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

Ying Sun, Jun Ma, A. Lin, 2018, Clinical Cancer Research.

Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.

S. Hee, I. Tham, R. Yeo, 2008, International journal of radiation oncology, biology, physics.

High-dimensional Characterization of the Systemic Immune Landscape Informs on Synergism between Radiotherapy and Immune Checkpoint Blockade.

K. Soo, M. Fehlings, M. Chua, 2020, International journal of radiation oncology, biology, physics.

Why are East Asians more susceptible to several infection-associated cancers (carcinomas of the nasopharynx, stomach, liver, adenocarcinoma of the lung, nasal NK/T-cell lymphomas)?

Joseph T. S. Wee, K. Yeoh, J. Wee, 2012, Medical hypotheses.

Thoughts on Beta-integrins and a postulated pathogenesis for nasopharyngeal carcinoma

J. Wee, S. Poh, 2018 .

A new prognostic histopathologic classification of nasopharyngeal carcinoma

H. Adami, Yih-Leong Chang, I. Ernberg, 2016, Chinese journal of cancer.

EBV and NPC carcinogenesis—an alternative viewpoint

J. Wee, S. Poh, Joseph T. S. Wee, 2021, Annals of Nasopharynx Cancer.

International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.

Brian O'Sullivan, Johannes A Langendijk, Cai Grau, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma

J. Wee, K. Fong, T. Tan, 1999, Cancer.

Intensity-modulated radiotherapy for paranasal sinuses and base of skull tumors.

M. Chua, G. Kusumawidjaja, J. Wee, 2018, Oral oncology.

Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma.

K. Soo, M. Chua, J. Wee, 2018, Chinese clinical oncology.

4th FY Khoo Memorial Lecture 2008: Nasopharyngeal Cancer Workgroup--the past, the present and the future.

J. Wee, 2008, Annals of the Academy of Medicine, Singapore.

Nasopharyngeal Cancer Workgroup – The Past , The Present and The Future

J. Wee, 2008 .

Treatment of Nasopharyngeal Carcinoma

J. Wee, 2003 .

Vocal fold paralysis following radiotherapy for nasopharyngeal carcinoma: laryngeal electromyography findings.

N. Tan, J. Wee, Y. Lo, 2003, Journal of voice : official journal of the Voice Foundation.

Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma.

I. Tham, J. Tuan, W. Ong, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.

Y. Mao, Jun Ma, N. Lee, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reporting Quality of Randomized, Controlled Trials Evaluating Combined Chemoradiotherapy in Nasopharyngeal Carcinoma.

Ying Sun, Jun Ma, B. O'Sullivan, 2017, International journal of radiation oncology, biology, physics.

Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC

K. Soo, M. Chua, Y. Soong, 2018, BMC Cancer.

Analysis and design of randomised clinical trials involving competing risks endpoints

D. Machin, B. Tai, J. Wee, 2011, Trials.

Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma.

Pheng-Ann Heng, Ying Sun, Qi Dou, 2019, Radiology.

Adaptive radiotherapy for head and neck cancers: Fact or fallacy to improve therapeutic ratio?

Janice Sio-Nee Tan, M. Chua, J. Wee, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiotherapy of NPC Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy

Ying Sun, Y. Mao, Jun Ma, 2014 .

Nasopharyngeal carcinoma: review of how imaging affects staging.

S. Ng, B. O'Sullivan, V. Chong, 1999, Journal of computer assisted tomography.

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.

D. Machin, E. Tan, B. Tai, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multimodality Management of Nasopharyngeal Carcinoma

E. Tan, J. Wee, K. Fong, 2005 .

Associations of lifestyle and diet with the risk of nasopharyngeal carcinoma in Singapore: a case–control study

V. Gaborieau, J. Wee, T. Ha, 2017, Chinese journal of cancer.

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis

Federico Rotolo, Stefan Michiels, George Fountzilas, 2017, Journal of the National Cancer Institute.

Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma.

K. Soo, Q. Ng, D. Tan, 2015, International journal of radiation oncology, biology, physics.

Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma

M. Chua, J. Khoo, J. Wee, 2009, Head & neck.

Nasopharyngeal cancer: a promising future.

J. Wee, 2012, The Lancet. Oncology.

Intensity-Modulated Radiation Therapy Without Concurrent Chemotherapy for Stage IIB Nasopharyngeal Cancer

Jianji Pan, I. Tham, Shaojun Lin, 2010, American journal of clinical oncology.

Brachytherapy boost for T1/T2 nasopharyngeal carcinoma

S. Hee, R. Yeo, J. Wee, 2009, Head & neck.

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type.

D Machin, D. Machin, E. Tan, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality-of-life-adjusted survival analysis of concurrent chemo radiotherapy for locally advanced (nonmetastatic) nasopharyngeal cancer.

D. Machin, J. Wee, H. Wong, 2010, International journal of radiation oncology, biology, physics.

Chemotherapy with or without radiotherapy in patients with locoregionally recurrent nasopharyngeal carcinoma

E. Tan, J. Wee, K. Fong, 2002, Head & neck.

Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging.

V. Goh, G. Cook, C. Yip, 2016, Chinese clinical oncology.

Proceedings of the 7th Biannual International Symposium on Nasopharyngeal Carcinoma 2015

Sugiyanto, Asma Abdul Rahman, C. Lemmen, 2016, BMC Proceedings.

Personalised medicine in nasopharyngeal cancer.

J. Wee, H. Toh, T. Ha, 2012, The Lancet. Oncology.

Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma.

Y. Cheung, E. Tan, J. Wee, 2004, International journal of radiation oncology, biology, physics.

18F-FMISO PET-guided dose escalation with multifield optimization intensity-modulated proton therapy in nasopharyngeal carcinoma.

Thng Choon Hua, K. Sommat, Y. Soong, 2023, Asia-Pacific journal of clinical oncology.

D. Machin, E. Tan, B. Tai, 2004 .

Patient profile and survival in 270 computer tomography-staged patients with nasopharyngeal cancer treated at the Singapore General Hospital.

J. Wee, K. Fong, T. Tan, 1996, Annals of the Academy of Medicine, Singapore.

Plasma EBV DNA as a Predictive Biomarker in Patients With Endemic Nasopharyngeal Carcinoma Treated With Induction Chemotherapy and Concurrent Chemoradiation Therapy

M. Chua, Y. Soong, J. Wee, 2014 .

Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)

M. Chua, J. Tien, J. Wee, 2009, Radiation oncology.

Nasopharyngeal carcinoma-past lessons and a glimpse into the future.

M. Chua, Y. Soong, J. Wee, 2016, Chinese clinical oncology.

28 : Final Report of SQNP01 - A Phase III Randomized Trial Comparing RT With Chemo-RT for Locally Advanced Nasopharyngeal Cancer

D. Machin, E. Tan, B. Tai, 2006 .

Recurrent nasopharyngeal carcinoma presenting as diffuse dermal lymphatic infiltration in the neck: Three case reports

N. Tan, E. Tan, W. Poh, 2001, Head & neck.

NASOPHARYNGEAL CARCINOMA IN YOUNG PATIENTS

J. Wee, A. Balakrishnan, Lhy Lim, 2003, International journal of clinical practice.

The Hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-Barr virus?

M. Chua, J. Wee, M. T. L. Tan, 2019, Translational cancer research.

The new front line in advanced nasopharyngeal cancer

K. Sommat, J. Wee, 2017 .

Is nasopharyngeal cancer really a "Cantonese cancer"?

C. Qian, J. Wee, T. Ha, 2010, Chinese journal of cancer.